Second neoplasms after acute lymphoblastic leukemia in childhood

New England Journal of Medicine

Volumn 325, Issue 19, 1991, Pages 1330-1336

  Neglia, Joseph P ^a   Meadows, Anna T ^c   Robison, Leslie L ^e   Kim, Tae H ^b   Newton, William A ^c   Ruymann, Frederick B ^c   Sather, Harland N ^d   Hammond, G Denman ^d  

^a Children's Cancer Study Group   (United States)

^b ABBOTT NORTHWESTERN HOSPITAL   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SECOND CANCER; SKULL IRRADIATION;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0026048607     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199111073251902     Document Type: Article

References (40)

1. Hammond GD. The cure of childhood cancers. Cancer 1986; 58:407–13.
2. Pinkel D. Curing children of leukemia. Cancer 1987; 59:1683–91.
3. Parkin DM, Stiller CA, Draper GJ, Bieber CA, Terracini B, Young JL. International incidence of childhood cancer. Lyon, France: International Agency for Research on Cancer, 1988. (IARC scientific publications no. 87.)
4. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. CA 1990; 40:9–26.
5. Zarrabi MH, Rosner F, Grunwald HW. Second neoplasms in acute lymphoblastic leukemia. Cancer 1983; 52:1712–9.
6. Mosijczuk AD, Ruymann FB. Second malignancy in acute lymphocytic leukemia. Am J Dis Child 1981; 135:313–6.
7. Pui C-H, Behm FG, Raimondi SC, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989:321: 136–42.
8. Nesbit ME, Sather H, Robison LL, et al. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia. Cancer Res 1982; 42:674–80.
9. Miller DR. Leikin SL, Albo VE, Sather HN, Karon M, Hammond GD. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. Cancer 1983; 51:1041–9.
10. Coccia PF. Development and preliminary findings of Children's Cancer Study Group protocols (161, 162 and 163) for low-, average- and high-risk acute lymphoblastic leukemia in children. In: Murphy SB, Gilbert JR, eds. Leukemia research: advances in cell biology and treatment. New York: Elsevier Biomedical, 1983:241–50.
11. Ortega JA, Nesbit ME Jr, Donaldson MH, et al. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res 1977; 37:535–40.
12. Steinherz PG, Gaynon P, Miller DR, et al. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen — a new intensive therapy protocol: a report from the Children's Cancer Study Group. J Clin Oncol 1986; 4:744–52.
13. Gaynon PS, Bleyer WA, Steinherz PG, et al. Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Am J Pediatr Hematol Oncol 1988; 10:42–50.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457–81.
15. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc [A] 1972; 135:185–206.
16. Kalbfleisch J, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980:14–5.
17. Breslow N. Covariance analysis of censored survival data. Biometrics 1974; 30:89–99.
18. Mantel N, Byar DP. Evaluation of response-time data involving transient states: an illustration using heart-transplant data. J Am Stat Assoc 1974; 69:81–6.
19. National Cancer Institute. Cancer statistics review, 1973–1986. Bethesda, Md.: National Cancer Institute, 1989. (NIH publication no. 829–2789.)
20. Bailar JC III, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 1964; 20:639–43.
21. Meadows AT, D'Angio GJ, Mike V, et al. Patterns of second malignant neoplasms in children. Cancer 1977; 40: Suppl 4:1903–11.
22. Mike V, Meadows AT, D'Angio GJ. Incidence of second malignant neoplasms in children: results of an international study. Lancet 1982; 2:1326–31.
23. Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985; 3:532–8.
24. Rimm U, Li FC, Tarbell NJ, Winston KR, Sallan SE. Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. Cancer 1987; 59:1506–8.
25. Labotka RJ, Sotelo-Avila C, Hruby MA. Hodgkin's disease in a child with acute lymphoblastic leukemia. Cancer 1983; 52:846–50.
26. Goldes J, Holmes S, Satz M, Cich J, Dehner L. Melanoma masquerading as Spitz nevus following acute lymphoblastic leukemia. Pediatr Dermatol 1984; 1:295–8.
27. Malone M, Lumley H, Erdohazi M. Astrocytoma as a second malignancy in patients with acute lymphoblastic leukemia. Cancer 1986; 57:1979–85.
28. Fried M, Kalra J, Hardi CF, Sawtisky A. Hepatocellular carcinoma in a long-term survivor of acute lymphocytic leukemia. Cancer 1987; 60:2548–52.
29. Pratt CB, George SL, Hannock ML, Hustu HO, Kun LE, Ochs JS. Second malignant neoplasms in survivors of childhood acute lymphocytic leukemia. Pediatr Res 1988; 23: Suppl: 345a. abstract.
30. Albo V, Miller D, Leiken S, Sather H, Hammond D. Nine brain tumors as a late effect in children “cured” of acute lymphoblastic leukemia from a single protocol study (141). Proc Am Soc Clin Oncol 1985; 4: 172. abstract.
31. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987; 56:339–47.
32. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317:588–93.
33. Farwell J, Flannery JT. Cancer in relatives of children with central-nervoussystem neoplasms. N Engl J Med 1984; 311:749–53.
34. Li FP, Fraumeni JF. Prospective study of a cancer family syndrome. JAMA 1982; 247:2692–4.
35. Malkin E, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233–8.
36. Sussman A, Leviton A, Allred EN, et al. Childhood brain tumor: presentation at younger age is associated with a family tumor history. Cancer Causes Control 1990; 1:75–9.
37. Meadows AT, Robison LL, Neglia JP, Sather H, Hammond D. Potential long-term toxic effects in children treated for acute lymphoblastic leukemia. N Engl J Med 1989: 321: 1830.
38. Pedersen-Bjergaard J, Daugaard G, Werner Hansen S, Philip P, Olesen Larsen S, Rorth M. Increased risk of myelodysplasia and leukemia following etoposide and cisplatin for germ cell tumors. Proc Am Soc Clin Oncol 1991; 10: 221. abstract.
39. Sullivan MP, Chen T, Dyment PG, Hvizdala E, Steuber CP. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a Pediatric Oncology Group study. Blood 1982; 60:948–58.
40. Littman P, Coccia P, Bleyer A, et al. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL). Int J Radiat Oncol Biol Phys 1987; 13:1443–9.